Table 2.
Variables | All lesions (n=125) | PMI (n=50) | Non‐PMI (n=75) | P value |
---|---|---|---|---|
Lesion characteristics | ||||
Target vessel: LAD/LCX/RCA, % | 53.6/16.0/30.4 | 56.0/20.0/24.0 | 52.0/13.3/34.7 | 0.39 |
Lesion location: proximal/mid/distal, % | 36.8/56.8/6.4 | 30.0/66.0/4.0 | 41.3/50.7/8.0 | 0.24 |
Multivessel disease | 73 (58.4%) | 30 (60%) | 43 (57.3%) | 0.77 |
Procedural characteristics | ||||
No. of stents | 1.21±0.43 | 1.28±0.45 | 1.16±0.40 | 0.12 |
Stent diameter, mm | 3.10±0.43 | 3.03±0.35 | 3.15±0.48 | 0.14 |
Stent length, mm | 30.0±14.5 | 34.2±14.9 | 27.1±13.5 | 0.007 |
Distal protection device, n (%) | 13 (10.4%) | 7 (14.0%) | 6 (8.0%) | 0.29 |
Angiographic analysis | ||||
Pre‐PCI | ||||
Reference vessel diameter, mm | 2.68±0.49 | 2.58±0.44 | 2.75±0.51 | 0.17 |
Minimum lumen diameter, mm | 1.08±0.40 | 0.98±0.31 | 1.04±0.25 | 0.20 |
Diameter stenosis, % | 57.6±11.9 | 59.3±10.0 | 57.2±11.1 | 0.30 |
Post‐PCI | ||||
Minimum lumen diameter, mm | 2.39±0.39 | 2.34±0.27 | 2.42±0.45 | 0.29 |
Diameter stenosis, % | 14.6±11.1 | 15.3±10.9 | 14.1±11.2 | 0.57 |
Transient no‐reflow, n (%) | 12 (9.6%) | 11 (22.0%) | 1 (1.3%) | <0.01 |
Final slow flow, n (%) | 5 (4.0%) | 5 (10.0%) | 0 (0.0%) | 0.005 |
Acute gain, mm | 1.36±0.58 | 1.43±0.48 | 1.31±0.63 | 0.27 |
QFR analysis | ||||
μQFR pre‐PCI | 0.68±0.16 | 0.69±0.13 | 0.68±0.17 | 0.96 |
μQFR post‐PCI | 0.89±0.09 | 0.92±0.06 | 0.87±0.10 | 0.01 |
IMR analysis | ||||
IMR pre PCI, mm Hg×s/cm | 29.8±9.7 | 34.5±8.1 | 26.6±9.5 | <0.001 |
IMR post‐PCI, mm Hg×s/cm | 33.4±11.5 | 43.0±10.5* | 27.0±6.6 | <0.001 |
ΔIMR, mm Hg×s/cm | 3.6±9.3 | 8.6±9.4 | 0.4±7.6 | <0.001 |
Values are expressed as mean±SD or n (%). μQFR indicates Murray's law‐based quantitative flow ratio; IMR, index of microvascular resistance; LAD, left anterior descending artery; LCX, left circumflex artery; PCI, percutaneous coronary intervention; PMI, periprocedural myocardial injury; QFR, quantitative flow ratio; and RCA, right coronary artery.
Indicates P<0.05 vs IMR pre‐PCI.